November 2025: FDA approved expanded Zepbound (tirzepatide) indication for moderate-to-severe obstructive sleep apnea in adults with obesity, following SURMOUNT-OSA trial data showing 62.8% reduction in apnea-hypopnea index the first drug approval for sleep apnea treatment
A newly-released March 2025 Washington State Department of Health video shows investigators raiding Aequita, a compounding pharmacy closely affiliated with Mochi Health, where cutting corners [was seen] at nearly every level of its operation. In the video, inspectors found imported peptide base powder, which Aequitas head of pharmacy operations said was six to nine times cheaper than American-made peptides, in a space that purportedly only contained packaging materials
Check out these examples of Happy Mammoths social media ads: Completely unbelievable, in so many ways
Notes: Researchers are advised to adhere to the recommendations and not exceed the daily liraglutide dose of 3mg
Zoe B.Treatment Knowledge, River North Chicago GLP-1 Weight Loss Treatments What You Can Expect Bespoke Consultation Your provider will review your medical history, body composition, and weight-loss goals
Building large-scale peptide manufacturing infrastructure takes 3-5 years and billions in capital expenditure not a constraint that can be resolved quickly regardless of investment commitment